Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

[1]  M. Perreault,et al.  Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster , 2023, PloS one.

[2]  V. Garrido,et al.  Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms , 2023, Nature Biotechnology.

[3]  B. Ye,et al.  Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. , 2022, Cell host & microbe.

[4]  Tal Danino,et al.  Engineering bacteria as interactive cancer therapies , 2022, Science.

[5]  S. Bullman,et al.  Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer , 2022, Nature.

[6]  Clare M. Robinson,et al.  Achieving spatially precise diagnosis and therapy in the mammalian gut using synthetic microbial gene circuits , 2022, Frontiers in Bioengineering and Biotechnology.

[7]  Randall J. Platt,et al.  Noninvasive assessment of gut function using transcriptional recording sentinel cells , 2022, Science.

[8]  M. Germani,et al.  Immune Checkpoint Inhibitors in Mismatch Repair Proficient/Microsatellite Stable Metastatic Colorectal Cancer Patients: Insights from the AtezoTRIBE and MAYA Trials , 2021, Cancers.

[9]  J. Hasty,et al.  Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes , 2021, Cell.

[10]  G. Wang,et al.  Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients , 2021, Frontiers in Immunology.

[11]  Manuela M. Santos,et al.  Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains , 2021, BMC cancer.

[12]  Tal Danino,et al.  Engineered Bacterial Production of Volatile Methyl Salicylate. , 2020, ACS synthetic biology.

[13]  A. Broeks,et al.  Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers , 2020, Nature Medicine.

[14]  Rob Knight,et al.  Microbiome analyses of blood and tissues suggest cancer diagnostic approach , 2020, Nature.

[15]  A. Need,et al.  Mutational signature in colorectal cancer caused by genotoxic pks+E. coli , 2020, Nature.

[16]  K. Neufeld,et al.  APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes , 2020, Scientific Reports.

[17]  D. Lieberman,et al.  Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer. , 2020, Gastroenterology.

[18]  Monjur Ahmed.  Colon Cancer: A Clinician’s Perspective in 2019 , 2020, Gastroenterology research.

[19]  Christian Munck,et al.  Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR-Cas spacer acquisition platform , 2020, Nature Communications.

[20]  Q. Qi,et al.  Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy , 2019, Microbial biotechnology.

[21]  G. S. Kew,et al.  Strategies to Improve Persistent Adherence in Colorectal Cancer Screening , 2019, Gut and liver.

[22]  J. Min,et al.  Bacteria-cancer interactions: bacteria-based cancer therapy , 2019, Experimental & Molecular Medicine.

[23]  Neel S. Joshi,et al.  Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut , 2019, Nature Communications.

[24]  Julia Oh,et al.  Recoding the metagenome: microbiome engineering in situ. , 2019, Current opinion in microbiology.

[25]  Z. Stadler,et al.  Immunotherapy in colorectal cancer: rationale, challenges and potential , 2019, Nature Reviews Gastroenterology & Hepatology.

[26]  Tal Danino,et al.  Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies , 2019, Science Translational Medicine.

[27]  Tal Danino,et al.  Programmable bacteria induce durable tumor regression and systemic antitumor immunity , 2019, Nature Medicine.

[28]  Robert D. Finn,et al.  A new genomic blueprint of the human gut microbiota , 2019, Nature.

[29]  B. Pfeifer,et al.  Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants , 2018, Front. Microbiol..

[30]  Itai Sharon,et al.  Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features , 2018, Cell.

[31]  James J. Collins,et al.  Probiotic strains detect and suppress cholera in mice , 2018, Science Translational Medicine.

[32]  J. Thiery,et al.  Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention , 2018, Nature Biomedical Engineering.

[33]  Tal Danino,et al.  Advances in bacterial cancer therapies using synthetic biology. , 2017, Current opinion in systems biology.

[34]  B. Leggett,et al.  Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis , 2017, Gut.

[35]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[36]  Mingwei Yu,et al.  Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis , 2017, Clinical and translational gastroenterology.

[37]  Elena Cerrada,et al.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.

[38]  J. Burn,et al.  The role of aspirin in preventing colorectal cancer. , 2016, British medical bulletin.

[39]  W. Garrett,et al.  Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. , 2016, Cell host & microbe.

[40]  M. Omar Din,et al.  Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.

[41]  Howard J. Li,et al.  Programmable probiotics for detection of cancer in urine , 2015, Science Translational Medicine.

[42]  P. Cossart,et al.  How bacterial pathogens colonize their hosts and invade deeper tissues. , 2015, Microbes and infection.

[43]  K. Kinzler,et al.  Microbiota organization is a distinct feature of proximal colorectal cancers , 2014, Proceedings of the National Academy of Sciences.

[44]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[45]  Maged Zeineldin,et al.  More than two decades of Apc modeling in rodents. , 2013, Biochimica et biophysica acta.

[46]  B. Finlay,et al.  Molecular mechanisms of Escherichia coli pathogenicity , 2012, Nature Reviews Microbiology.

[47]  Jeff Hasty,et al.  In Vivo Gene Expression Dynamics of Tumor-Targeted Bacteria , 2012, ACS synthetic biology.

[48]  N. Forbes.  Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.

[49]  W. Kruis,et al.  Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers , 2010, Inflammatory bowel diseases.

[50]  Yong A. Yu,et al.  Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria , 2008, Biotechnology and bioengineering.

[51]  M. Neurath,et al.  High resolution colonoscopy in live mice , 2006, Nature Protocols.

[52]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[53]  A. B. Graham,et al.  Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin , 2003, Journal of clinical pathology.

[54]  Elizabeth M. Webber,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[55]  Jeffrey J. Tabor,et al.  Molecular Systems Biology Peer Review Process File Engineering Bacterial Thiosulfate and Tetrathionate Sensors for Detecting Gut Inflammation Editor: Maria Polychronidou Transaction Report , 2022 .